Prostate cancer
Treatment selection in mCRPC patients harbouring HRR gene mutationsCase 2: Artur
Artur, 71 years old, has a history of PCa.
Medical history:
- Diagnosed with high-volume mHSPC 4 years ago
- PSA: 128 ng/ml
- Bone and CT scan: multiple bone metastases
- Treatment with ADT + enzalutamide was started
- PSA nadir was 0.7 ng/ml
Current situation:
- ECOG PS: 0
- Symptoms: mild back pain, under control with NSAIDs
- Bone and CT scan: progression of bone metastases, few positive pelvic and retroperitoneal lymph nodes (all <3 cm), no visceral metastases
- PSMA-PET/CT: concordant with CT and bone scan, all lesions PSMA positive and higher PSMA expression than liver
- Testosterone: 19 ng/dl (0.7 nmol/L)
- Somatic tumour testing: ATM mutation